**Core Concept**
The drug of choice for attention deficit hyperactivity disorder (ADHD) is a central nervous system stimulant that enhances dopaminergic and norepinephrinergic transmission in the prefrontal cortex and striatum, improving focus and reducing impulsivity.

**Why the Correct Answer is Right**
Methylphenidate is a potent central nervous system stimulant that crosses the blood-brain barrier and inhibits the reuptake of dopamine and norepinephrine. By increasing synaptic levels of these neurotransmitters, it enhances executive function and attention control in ADHD patients. It is well-established in clinical guidelines (e.g., NICE, AAP) as first-line treatment due to its efficacy, safety, and long-term benefits.

**Why Each Wrong Option is Incorrect**
Option B: Modafinil is a wakefulness-promoting agent used in narcolepsy and sleep disorders, not ADHD. It has minimal effect on dopamine in the prefrontal cortex and is not approved for ADHD.
Option C: Amitriptyline is a tricyclic antidepressant with weak anticholinergic and serotonergic effects; it is not indicated for ADHD and may worsen symptoms.
Option D: Adrenaline (epinephrine) acts primarily in the periphery and has no established role in treating ADHD; it causes anxiety, tachycardia, and is not used therapeutically for this condition.

**Clinical Pearl / High-Yield Fact**
Methylphenidate is the most widely used and evidence-based treatment for ADHD, with a strong effect on core symptoms. It works best in children and adolescents and is typically prescribed as immediate-release or extended-release formulations.

✓ Correct Answer: A. Methylphenidate